CBD for Anxiety: Independent Evidence on Sleep, Liver Risk & Law
CBD calmed nerves in small one-off public-speaking tests, but trials in diagnosed anxiety are few and mixed, and an FDA trial found liver-enzyme rises at consumer-range doses.
Evidence-graded research on sleep and insomnia — melatonin, magnesium and other sleep supplements assessed by the real strength of the primary evidence.
CBD calmed nerves in small one-off public-speaking tests, but trials in diagnosed anxiety are few and mixed, and an FDA trial found liver-enzyme rises at consumer-range doses.
Prazosin helped PTSD nightmares in small trials, but the largest VA trial was negative. We weigh the evidence, blood pressure risks and who paid.
Guided digital CBT and insomnia programmes work; self-help apps and chatbots help less than claimed. We review the trials, NICE and FDA decisions, privacy cases and who paid for the evidence.
Kava may ease anxiety slightly, but the largest independent trial found no benefit for generalised anxiety disorder, and it carries a rare risk of serious liver injury.
5-HTP and L-tryptophan show hints of benefit for depression, but the best evidence is small and old. We trace the EMS outbreak, serotonin syndrome risks and who paid for the research.
Does a GABA supplement calm stress or help sleep? Independent evidence on the trials, the blood–brain barrier question, safety, regulation and who funds the research.
Passionflower is sold for stress and sleep on traditional use. We review the small trials, safety signals, combination products and who funded the evidence.
Lemon balm is an EU traditional remedy for mild stress and sleep. Small trials hint at modest benefits; we trace who funded them and the thyroid and sedation cautions.
Lormetazepam for severe insomnia: product differences, withdrawal, overdose, driving, pregnancy, breastfeeding and funding limits.
Loprazolam (Dormonoct, Havlane): severe insomnia, dependence, withdrawal, overdose, driving, pregnancy and breastfeeding cautions.
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.